Begin main content

Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Clinical Effectiveness and Guidelines

Last updated: November 1, 2016
Project Number: RB1032-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis?
  2. What are the evidence-based guidelines regarding hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis?

Key Message

Two systematic reviews, two randomized controlled trials, four non-randomized studies, and one evidence-based guideline were identified regarding hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis.